Cite
HARVARD Citation
Hodi, F. et al. (2021). Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218). Melanoma research. 31 (1), pp. 67-75. [Online].